UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 26, 2022
Accession Number:
0001193125-22-111227
Submission Type:
POS AM
CIK:
0001833214
Company Name:
SAB Biotherapeutics, Inc.
File Number:
333-261496